@misc{indiciaef94b002e4fde,
  title = {[Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse events. Data from the Evaluation of Platelets IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial].},
  author = {S De Servi},
  year = {2001},
  url = {https://pubmed.ncbi.nlm.nih.gov/11508303/},
  note = {Source identifier: 11508303}
}